17 August 2021 in Acta Pharmaceutica Sinica B
With the understanding of microRNA (miRNA or miR) functions in tumor initiation, progression, and metastasis, efforts are underway to develop new miRNA-based therapies. Very recently, we demonstrated effectiveness of a novel humanized bioengineered miR-124-3p prodrug in controlling spontaneous lung metastasis in mouse models. This study was to investigate the molecular and cellular mechanisms by which miR-124-3p controls tumor metastasis. Proteomics study identified a set of proteins selectively and significantly downregulated by bioengineered miR-124-3p in A549 cells, which were assembled into multiple cellular components critical for metastatic potential. Among them, plectin (PLEC) was verified as a new direct target for miR-124-3p that links cytoskeleton components and junctions. In miR-124-3p-treated lung cancer and osteosarcoma cells, protein levels of vimentin, talin 1 (TLN1), integrin beta-1 (ITGB1), IQ motif containing GTPase activating protein 1 (IQGAP1), cadherin 2 or N-cadherin (CDH2), and junctional adhesion molecule A (F11R or JAMA or JAM1) decreased, causing remodeling of cytoskeletons and disruption of cell–cell junctions. Furthermore, miR-124-3p sharply suppressed the formation of focal adhesion plaques, leading to reduced cell adhesion capacity. Additionally, efficacy and safety of biologic miR-124-3p therapy was established in an aggressive experimental metastasis mouse model in vivo. These results connect miR-124-3p−PLEC signaling to other elements in the control of cytoskeleton, cell junctions, and adhesion essential for cancer cell invasion and extravasation towards metastasis, and support the promise of miR-124 therapy.
1 September 2020 in International Journal of Surgery
Gustilo-Anderson type III traumas have been described as high-energy injuries with severe bone defects and extensive soft tissue damage, which remain a challenging entity, due to an inherent risk of infection, nonunion and even amputation. The emergency management of such severe trauma presents additional difficulties. Our study attempts to retrospectively evaluate the Masquelet technique combined with the muscle flap for the management of Gustilo type III trauma of the lower limb with segmental bone loss in emergencies and assess key points of success in this technique. From June 2014 to December 2017, 17 patients of Gustilo type IIIA/B/C trauma of lower limb with segmental bone loss, were recruited for our studies. All the cases experienced thorough debridement, stabilization of fracture and antibiotic-impregnated cement spacer insertion. When necessary, muscle flap surgeries were performed immediately. After wound healing, cement spacers were removed, and cancellous bone was filled to repair bone defects. Procedures were performed by two experienced orthopedic surgeons. Among the patients studied, retrograde translocations of the medial head of the gastrocnemius were performed in 5 cases, medial hemimuscular flaps of soleus in 3 cases, and medial head of the gastrocnemius combined with medial hemimuscular flaps of soleus in 4 cases. One patient developed a necrotic soleus flap and was treated with the cross-leg flap. Using a mean 28.2 months of follow-up, results were analyzed radiologically and clinically. Failures (include infection and nonunion) were not noted. And all the patients returned to full weight bearing without pain. According to the Paley fracture healing score, 15 patients showed excellent results and 2 patients displayed good results regarding bone outcomes. When considering functional outcomes, 14 patients exhibited excellent results and 3 patients displayed good results. The muscle flap is synergistic with the Masquelet technique in the emergency management of severe complex fractures. The combination of both techniques in emergency surgery demonstrates an alternative option for the treatment of acute Gustilo type III trauma of the lower limb with segmental bone loss, which can effectively prevent bone infection and amputation. We also demonstrate that firm fixation is key to the Masquelet technique.
3 October 2019 in Journal of International Medical Research
Chondrosarcoma is characterized by the presence of histologically aggressive behavior, and commonly involves the scapula. Currently, limb salvage surgery is the recommended surgical treatment. Owing to the irregularity of the tumor, the suitability of an implant after tumor resection is a challenge for surgeons. Three-dimensional (3D) printing technology has the potential to make personalized limb salvage surgery a reality. We report the case of a 53-year-old man who was diagnosed with chondrosarcoma of the scapula. Considering the low-grade malignancy and lack of invasion of the glenoid, we agreed upon segmental scapula replacement as the treatment protocol. Nevertheless, reconstruction of the irregular bony defect remaining after tumor resection can be complicated. Therefore, a personalized prosthesis and navigation template corresponding to tumor was designed with 3D printing technique, and tumor resection, prosthesis implantation, and rotator cuff reconstruction were completed. The affected shoulder achieved satisfactory function during a 32-month follow-up with no tumor recurrence. 3D printing technique can help implement the individualized design of the implant and accurate reconstruction after tumor resection, simplify complicated operations, improve operational efficiency, and allow early functional recovery.
1 April 2026 in The Bone & Joint Journal
Aims: This prospective study investigated an innovative approach to the management of extruded or devitalized fragments of bone in patients with a Gustilo type III open fracture of the tibia, which enabled the efficient reconstruction of the bony defect while minimizing the requirement for iliac bone harvesting. Methods: A total of 12 patients with a Gustilo type III open fracture were enrolled into the study between June 2019 and June 2022. During initial emergency management, all patients were treated with radical debridement, the introduction of an antibiotic-loaded spacer, and stabilization of the fracture. Extruded or devitalized fragments, including detached and potentially contaminated segments, were collected and processed into autologous demineralized bone matrix (ADBM). In the second stage, after removal of the spacer, ADBM combined with iliac bone graft was implanted into the induced membrane cavity for reconstruction of the bony defect. The sterility of the ADBM specimens was assessed using microbiological culture. Volumetric analysis of iliac graft requirements was performed. Primary outcome measures including time to healing of the fracture and complications were recorded. The recovery of function was assessed using the Lower Extremity Functional Scale (LEFS) at final follow-up. Results: The mean follow-up was 32.5 months (24 to 48). No bacteria were detected in any ADBM implants. Complete reconstruction of the defect was achieved in all patients. Quantitative volume analysis revealed an autogenous bone-to-ADBM ratio of 1.36:1, reducing the autologous bone requirements. Radiological union occurred at a mean of seven months (5 to 10) after the second surgical stage. There were no complications such as rejection, infection, nonunion, or refracture. At the last follow-up, all patients had regained satisfactory function of the lower limb as recorded by a mean LEFS score of 72.2 (68 to 76). Conclusion: The processing of comminuted extruded or devitalized fragments of bone into ADBM represents a safe and effective strategy for managing severe open fractures of the tibia. When synergistically integrated with an induced membrane technique, this innovative approach considerably reduced the incidence of infection, diminished the need for iliac bone graft, and substantially enhanced the efficiency of reconstruction of the bony defect. Cite this article: Bone Joint J 2026;108-B(4):544–552.
5 July 2023 in Acta Pharmaceutica Sinica B
[This corrects the article DOI: 10.1016/j.apsb.2021.07.027.].